Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population. / Rasmussen, Katrine L.; Tybjærg-Hansen, Anne; Nordestgaard, Børge G; Frikke-Schmidt, Ruth.
I: Atherosclerosis, Bind 246, 03.2016, s. 63-70.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population
AU - Rasmussen, Katrine L.
AU - Tybjærg-Hansen, Anne
AU - Nordestgaard, Børge G
AU - Frikke-Schmidt, Ruth
N1 - Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
PY - 2016/3
Y1 - 2016/3
N2 - BACKGROUND AND AIMS: Triglyceride-rich lipoproteins are causally associated with high risk of ischemic heart disease (IHD), and apolipoprotein E (apoE) has a central role in their plasma clearance. While both quantitative and qualitative changes of apoE are established causes of rare dyslipidemia syndromes, it remains unclear whether plasma levels of apoE are associated with risk of IHD in the general population.METHODS: We tested whether plasma levels of apoE at enrollment were associated with future risk of IHD and myocardial infarction (MI) in 91,695 individuals from the general population.RESULTS: Multifactorially adjusted hazard ratios (HRs) for highest versus lowest apoE tertile were 1.15 (1.04-1.27) for IHD and 1.16 (1.00-1.36) for MI in men, and 0.94 (0.84-1.05) and 1.04 (0.85-1.26) in women. These associations were attenuated by adjustments for triglyceride levels. Corresponding HRs for highest versus lowest apoE tertile in ε33 carriers were 1.18 (1.03-1.36) for IHD and 1.21 (0.98-1.49) for MI in men, and 0.91 (0.78-1.06) and 0.93 (0.71-1.21) in women. Thus, the present associations were independent of APOE genotype.CONCLUSION: These findings suggest that high plasma levels of apoE are associated with IHD in men but not in women. Triglyceride-rich lipoproteins may partly explain these associations.
AB - BACKGROUND AND AIMS: Triglyceride-rich lipoproteins are causally associated with high risk of ischemic heart disease (IHD), and apolipoprotein E (apoE) has a central role in their plasma clearance. While both quantitative and qualitative changes of apoE are established causes of rare dyslipidemia syndromes, it remains unclear whether plasma levels of apoE are associated with risk of IHD in the general population.METHODS: We tested whether plasma levels of apoE at enrollment were associated with future risk of IHD and myocardial infarction (MI) in 91,695 individuals from the general population.RESULTS: Multifactorially adjusted hazard ratios (HRs) for highest versus lowest apoE tertile were 1.15 (1.04-1.27) for IHD and 1.16 (1.00-1.36) for MI in men, and 0.94 (0.84-1.05) and 1.04 (0.85-1.26) in women. These associations were attenuated by adjustments for triglyceride levels. Corresponding HRs for highest versus lowest apoE tertile in ε33 carriers were 1.18 (1.03-1.36) for IHD and 1.21 (0.98-1.49) for MI in men, and 0.91 (0.78-1.06) and 0.93 (0.71-1.21) in women. Thus, the present associations were independent of APOE genotype.CONCLUSION: These findings suggest that high plasma levels of apoE are associated with IHD in men but not in women. Triglyceride-rich lipoproteins may partly explain these associations.
KW - Aged
KW - Apolipoproteins E
KW - Biomarkers
KW - Chi-Square Distribution
KW - Denmark
KW - Female
KW - Genotype
KW - Humans
KW - Kaplan-Meier Estimate
KW - Linear Models
KW - Logistic Models
KW - Male
KW - Middle Aged
KW - Multivariate Analysis
KW - Myocardial Infarction
KW - Myocardial Ischemia
KW - Phenotype
KW - Proportional Hazards Models
KW - Prospective Studies
KW - Risk Assessment
KW - Risk Factors
KW - Time Factors
KW - Triglycerides
U2 - 10.1016/j.atherosclerosis.2015.12.038
DO - 10.1016/j.atherosclerosis.2015.12.038
M3 - Journal article
C2 - 26761769
VL - 246
SP - 63
EP - 70
JO - Atherosclerosis
JF - Atherosclerosis
SN - 0021-9150
ER -
ID: 173986890